The company is designing colon-targeted tablets aimed first at left-sided ulcerative colitis. Neither peptide is FDA-approved, and the pathway carries strict conditions.
Recap by typeshit. Full story at Investing News Network.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
A Dongguk University family medicine professor calls gallbladder risk the real concern and says some Koreans fly to Japan, where the drugs reportedly cost about a third.
He says GLP-1s help people with obesity, but taking tirzepatide just to get lean brought him dizziness, low intake and declining gym performance.
Loading…